Chen Kang, Li Qiaolin, Zhao Xingyang, Zhang Jinde, Ma Haosong, Sun Xiang, Yu Qian, Zhang Yueming, Fang Chihua, Nie Liming
Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, PR China.
Center for Molecular Imaging and Translational Medicine, School of Public Health, Xiamen University, Xiamen, 361102, PR China.
Biomater Sci. 2020 Jul 28;8(15):4322-4333. doi: 10.1039/d0bm00825g.
Early diagnosis and therapy of hepatocellular carcinoma (HCC) is critical to improve the five-year survival rates of patients. Theranostic agents synergized with photothermal ablation are expected to realize the early detection and treatment of orthotopic HCC. However, conventional metallic nanoagents are limited by their potential bio-toxicity to surrounding normal organs. Recently, endogenous biological melanin pigments have been utilized to develop nanoplatforms due to their excellent biocompatibility and degradability. Whereas, the insufficient capability of PEGylated melanin nanoparticles (PEG-MNPs) in photoacoustic (PA) imaging limits their further biomedical applications. Paradoxically, it is difficult to meet these two different requirements. Herein, a multifunctional nanoagent based on melanin (MNPs) conjugating the near-infrared (NIR) dye IR820 was successfully designed and fabricated. Encapsulation by polyethylene glycol (PEG) renders the solubility in water and allows the physical absorption of IR820 for enhanced photoacoustic (PA) performance and photothermal therapy. Besides, PEG coating on the surface of IR820-PEG-MNPs resulted in a reduction in swallowing in the reticuloendothelial system of the liver and spleen, prolonging the circulation time in the blood and increasing the accumulation in the tumor. The IR820-PEG-MNPs displayed satisfactory PA and T1-weighted magnetic resonance imaging (MRI) signals in aqueous solution as well as strong photothermal efficiency. Compared with prior injection, PA/MR signals of the tumor region were enhanced by 4.13- and 1.60-fold, respectively, which could effectively detect lesions smaller than ∼1.8 mm. Furthermore, the high photothermal conversion efficiency (40.2%) endowed the IR820-PEG-MNPs with the capability of selectively ablating tumors in orthotopic HCC mouse models under the guidance of PA/MR imaging. This work broadens the biomedical applications of melanin-based agent, which are promising for the precise diagnosis of orthotopic micro HCC and imaging guided photothermal ablation.
肝细胞癌(HCC)的早期诊断和治疗对于提高患者的五年生存率至关重要。与光热消融协同作用的诊疗剂有望实现原位HCC的早期检测和治疗。然而,传统的金属纳米剂受到其对周围正常器官潜在生物毒性的限制。最近,内源性生物黑色素因其优异的生物相容性和可降解性而被用于开发纳米平台。然而,聚乙二醇化黑色素纳米颗粒(PEG-MNPs)在光声(PA)成像方面的能力不足限制了它们进一步的生物医学应用。矛盾的是,很难同时满足这两个不同的要求。在此,成功设计并制备了一种基于黑色素(MNPs)并结合近红外(NIR)染料IR820的多功能纳米剂。聚乙二醇(PEG)包封使其在水中具有溶解性,并允许物理吸附IR820以增强光声(PA)性能和光热治疗效果。此外,IR820-PEG-MNPs表面的PEG涂层减少了在肝脏和脾脏网状内皮系统中的吞噬作用,延长了在血液中的循环时间并增加了在肿瘤中的蓄积。IR820-PEG-MNPs在水溶液中显示出令人满意的PA和T1加权磁共振成像(MRI)信号以及强大的光热效率。与预先注射相比,肿瘤区域的PA/MR信号分别增强了4.13倍和1.60倍,这可以有效检测小于约1.8 mm的病变。此外,高光热转换效率(40.2%)使IR820-PEG-MNPs能够在PA/MR成像引导下选择性地消融原位HCC小鼠模型中的肿瘤。这项工作拓宽了基于黑色素的试剂的生物医学应用,有望用于原位微小HCC的精确诊断和成像引导的光热消融。